Co-enrollment:

GuARDS has co-enrollment agreements with the following studies:

• ABBRUPT
• ABC Post-ICU
• AIRWAYS-3
• ASPECT
• AWAKE-PRONE (domain trial part of CoReCCT)
• BathMat
• Cardiac patients’ and their families’ perceptions of recovery after critical illness
• CHARM
• CogniShine
• DAYDREAM
• EMErALD
• EMUs
• FLO-ELA
• GenOMICC
• GUT-BIOME
• HITEC
• INFINIT
• INSIGHT
• iRehab
• MAP-ALF
• MARCH
• MEC-ROX
• MOSAICC
• NOTE-AF
• PANTHER (only co-enrol with the simvastatin arm)
• PERTAKI
• POS ARI ER
• PQIP
• PROTECT Airways (domain trial part of CoReCCT)
• ROMEO
• RELEASE (domain trial part of CoReCCT)
• REMAP-CAP (Antibiotic, macrolide and influenza antiviral domains only)
• SepTIC
• SHORTER
• SINFONIA
• SOS
• SPICE IV
• STEPCARE
• Threshold for Platelets (T4P)
• UK NAVA (NAVA part of CoReCCT)
• UK-ROX
• UNIVERSAL
• VitDalize UK

If you have any questions about co-enrollment, please contact us.